-+ 0.00%
-+ 0.00%
-+ 0.00%

X4 PHARMACEUTICALS - EXPECTS PHASE 3 4WARD TRIAL ENROLLMENT BY YEAR-END 2026, TOPLINE DATA IN H1 2028

Reuters·10/08/2026 11:00:09

Please log in to view news